Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs) (Seva)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01963234|
Recruitment Status : Completed
First Posted : October 16, 2013
Last Update Posted : February 21, 2018
|Condition or disease|
|Substance Use Disorders HIV|
|Study Type :||Observational|
|Actual Enrollment :||268 participants|
|Official Title:||Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)|
|Actual Study Start Date :||March 2014|
|Actual Primary Completion Date :||June 30, 2017|
|Actual Study Completion Date :||June 30, 2017|
Up to 100 patients in each of 3 intervention clinics will receive access to the Seva mobile health system for drug use disorders.
- Implementation status [ Time Frame: up to 3 years ]To measure implementation progress, we will adapt our implementation model intervention into a specific implementation plan (including timetables) for each clinic. We employ the Stages of Implementation Completion model (Chamberlain et al., 2011) to assess the degree of implementation. Each of the 8 phases of the implementation completion model is prospectively broken down into discrete tasks and events. We will assess whether each task/event was implemented and the length of time each one took to implement. Starting at the beginning of the implementation planning period (4 months before the first patient accesses Seva), the checklist will be reviewed and updated monthly by the implementation program leader, with responses verified by the clinic coach.
- Number of patients using system [ Time Frame: up to 3 years ]
- Clinical adoption [ Time Frame: up to 3 years ]We will analyze computerized system log files to produce metrics about patterns of system adoption by patients and staff. We will assess the characteristics of staff members (job function, years with clinic, etc.) and patients (age, gender, race, etc.) to determine individual characteristics associated with the degree of adoption.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01963234
|United States, Montana|
|Partnership Health Center|
|Missoula, Montana, United States|
|United States, New York|
|Institute for Family Health|
|Bronx, New York, United States|
|United States, Wisconsin|
|UW Health Access Clinic|
|Madison, Wisconsin, United States, 53706|